Technical Articles

The interleukin-31 receptor alpha subunit (IL-31RA) has become an important target in the treatment of chronic inflammatory skin diseases. As a receptor primarily expressed on the surface of peripheral sensory neurons and some immune cells, IL-31RA activates downstream signaling pathways upon binding to the ligand IL-31, directly participating in the generation and transmission of itch signals.